- Carbon Disclosure Project rates Evonik on very high level
- Reporting completeness well above the average
- Inclusion in three renowned sustainability indexes
Essen. The Carbon Disclosure Project (CDP) rated Evonik on a very high level when it participated in the Investor CDP for the first time. CDP works worldwide on behalf of investors to gather data on greenhouse gas emissions from companies as well as information on climate strategies and their implementation. The organization represents 767 investors with assets of US$92 trillion. For the so-called Climate Disclosure Score, which illustrates the completeness of the reporting, Evonik received 91 points out of 100. In comparison: On average, participating companies from Germany, Austria, and Switzerland received 69 points. Evonik received a B for its Climate Performance Score. On a scale of A to E, C is the average rating. The rating reflects the quality of the reporting in association with the management performance actually delivered.
In addition, Evonik was also recently included in the stock market indexes for responsible investment FTSE4Good Europe and FTSE4Good Global. STOXX Limited recently added the company to the index of Global ESG Leaders. When it comes to sustainability performance, rating agency Sustainalytics places Evonik in the top 5 out of 157 companies currently under consideration in the industry.
Since Evonik’s IPO last year the company is increasingly attracting the attention of financial investors and analysts, who base their investment decisions on companies’ sustainability performance in addition to financial performance. Rating agencies active in this area analyze and evaluate companies according to their handling of economic, ecological, and social opportunities and risks.
For more information go to: www.evonik.com under Investor Relations.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.